45 followers
https://t.co/R0s4NZ9cwu 一方で、薬物加療の主役のSRLsで生化学的にコントロールできていても、先端巨大症患者のQOLはまだ改善の余地あり
https://t.co/R0s4NZ9cwu 一方で、薬物加療の主役のSRLsで生化学的にコントロールできていても、先端巨大症患者のQOLはまだ改善の余地あり
RT @FrontEndocrinol: New Research: Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Inj…
New Research: Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands: Medical treatment for acromegaly commonly involves receiving intramuscular… https://t.co/5oZt8qYE7E